Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
AstraZeneca
Queensland Health
Teva
UBS
Covington
Accenture
Cantor Fitzgerald
Baxter

Generated: May 22, 2018

DrugPatentWatch Database Preview

EXTRA-STRENGTH AIM Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Extra-strength Aim patents expire, and when can generic versions of Extra-strength Aim launch?

Extra-strength Aim is a drug marketed by Chesebrough Ponds and is included in one NDA.

The generic ingredient in EXTRA-STRENGTH AIM is sodium monofluorophosphate. There are one thousand four hundred and twenty-six drug master file entries for this compound. Additional details are available on the sodium monofluorophosphate profile page.
Summary for EXTRA-STRENGTH AIM
Drug patent expirations by year for EXTRA-STRENGTH AIM
Synonyms for EXTRA-STRENGTH AIM
10163-15-2
12331-99-6
7631-97-2
A838673
AC1L2NBO
AC1Q1USA
AC1Q1USB
ACMC-20al4i
AI3-16931
Aim (TN)
AK397873
AKOS015916166
AKOS015960447
AN-18273
AN-21800
BFDWBSRJQZPEEB-UHFFFAOYSA-L
C810JCZ56Q
CCG-213673
CCRIS 9129
CHEBI:86431
CHEMBL1908359
Colgate anticavity toothpaste
CTK0G9476
D05864
D07FTD
dinatriumfluorophosphat
dipotassium fluoro-phosphite ion
disodium fluoranyl-bis(oxidanidyl)-oxidanylidene-$l^{5}-phosphane
disodium fluoro-dioxido-oxo-
disodium fluoro-dioxido-oxo-$l^{5}-phosphane
disodium fluoro-dioxido-oxophosphorane
Disodium fluorophosphate
Disodium monofluorophosphate
Disodium phosphorofluoridate
Disodiummonofluorophosphate
EC 233-433-0
EINECS 231-552-2
EINECS 233-433-0
Fluoridophosphoric acid disodium salt
FLUOROPHOSPHONATE
Fluorophosphoric acid, sodium salt
FNa2O3P
FT-0688148
HMS3264B14
I14-53894
IN002017
IN005964
IN011958
IN011959
KS-00000VJ6
KSC169I7N
LS-108318
MFCD00014248
MolPort-002-497-757
NSC 248
Phoskadent NA211
Phosphorofluoridic acid, disodium salt
Phosphorofluoridic acid, sodium salt
Phosphorofluoridic acid, sodium salt (1:?)
phosphorofluoridic acid,sodium salt
PHOSPHOROFLUORIDICACID, DISODIUM SALT (8CI,9CI)
RL00084
RT-000447
Sodium fluorophosphate
Sodium fluorophosphate (Na2PO3F)
Sodium fluorophosphate, 95%
SODIUM MONOFLUOROPHOSPHATE
Sodium monofluorophosphate (USP)
Sodium monofluorophosphate [USAN]
Sodium monofluorophosphate [USP]
SODIUM MONOFLUOROPHOSPHATE, Na2PO3F
Sodium phosphorofluoridate
UNII-C810JCZ56Q

US Patents and Regulatory Information for EXTRA-STRENGTH AIM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chesebrough Ponds EXTRA-STRENGTH AIM sodium monofluorophosphate GEL;DENTAL 019518-002 Aug 6, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Chesebrough Ponds EXTRA-STRENGTH AIM sodium monofluorophosphate PASTE;DENTAL 019518-001 Jun 3, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Queensland Health
Colorcon
Harvard Business School
Cantor Fitzgerald
Chubb
Julphar
Deloitte
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.